EA also attenuates pulmonary vascular remodeling, via pathways involving vascular endothelial growth factor (VEGF)/phosphoinositide 3-kinases (PI3K)/Akt and ET-1 reduction, in rats affected by COPD [252]. The gene discussed is VEGFA; the disease is chronic obstructive pulmonary disease.